美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,327.58

-9.1315-0.68%

涨家数：5

跌家数：15

平家数：- -

市盈率：- -

高：1,343.21

开：1,342.69

低：1,326.57

收：1,336.71

数据加载中...

总览新闻资讯

新事 | 罗氏、阿斯利康在中国又有大动作

Co-Diagnostics, Inc.盘中异动早盘大幅上涨5.69%

Nanoviricides, Inc.盘中异动早盘大幅拉升7.18%报1.33美元

阿斯利康盘中异动快速下挫3.05%

吉利德科学盘中异动急速下挫3.02%

Vir Biotechnology, Inc.盘中异动早盘大幅下跌5.43%

诺瓦瓦克斯医药盘中异动早盘股价大涨21.18%报7.21美元

BUZZ-疫苗生产商第一季度扭亏为盈，Novavax 跳涨

阿斯利康退出CNS，释放的两个信号

万艾可制造商 Viatris 因中国市场对品牌药的需求而超出季度预期

Novavax 称正在与 FDA 就 COVID 疫苗审批进行谈判，以平息投资者的担忧

总投资4.75亿美元阿斯利康无锡小分子药物新工厂正式开工

总投资4.75亿美元阿斯利康无锡小分子药物新工厂正式开工

维尔生物技术公司公布截至 3 月 31 日的季度业绩 - 收益摘要

吉利德：再投资110亿美元增建美国工厂

生物药大时代

莫德纳5月7日成交额为2.61亿美元

吉利德科学再投资110亿美元扩充美国药厂设施

吉利德科学5月7日成交额为8.03亿美元

雅培5月7日成交额为6.58亿美元

吉利德公司宣布在美国新投资 110 亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=2&region=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1327.5806,"timestamp":1746820799999,"preClose":1336.712,"halted":0,"volume":113582454,"delay":0,"changeRate":-0.006831,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-9.13147,"latestTime":"05-09 16:00:00 EDT","open":1342.69,"high":1343.2052,"low":1326.5701,"amount":4653162209.902576,"amplitude":0.012445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.574095,"peRate":21.454016,"turnoverRate":0.007317,"increases":5,"decrements":15,"flats":0,"marketCap":1093969830401.5,"floatMarketCap":1075897192963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1343.2052,"amplitude":0.012445,"preClose":1336.712,"low":1326.5701,"pbRate":"3.574095","latestPrice":1327.5806,"volume":113582454,"delay":0,"open":1342.69,"prevYearClose":1274.8187,"prevWeekClose":1375.2667,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1375.2667,"twentyDayClose":1281.7616,"sixtyDayClose":1380.7908,"secType":"PLATE","market":"US","turnoverRate":0.007317,"peRate":21.454016,"marketCap":1093969830401.5,"floatMarketCap":1075897192963,"timestamp":1746820799999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533131009","title":"新事 | 罗氏、阿斯利康在中国又有大动作","url":"https://stock-news.laohu8.com/highlight/detail?id=2533131009","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533131009?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 22:11","pubTimestamp":1746713495,"startTime":"0","endTime":"0","summary":"5月8日，罗氏制药中国宣布投资20.4亿元，用于在上海新建生物制药生产基地。本次投资用于法瑞西单抗注射液的本地化生产 ，不断满足中国患者对于创新疗法需求。这个投资项目位于张江高科技园区，建筑面积约2.5万平方米，是罗氏制药在中国的第二个创新药物生产基地。待建成之后，将与百米之外的罗氏制药中国区总部现有生产基地协同运作。同样在5月8日，阿斯利康无锡小分子药物新工厂项目开工。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508222524a6d7d211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508222524a6d7d211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU2417539215.USD","BK4588","LU2462157665.USD","BK4007","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","AZN","BK4585","LU1829250122.USD","LU2236285917.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2533394341","title":"Co-Diagnostics, Inc.盘中异动 早盘大幅上涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533394341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533394341?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:52","pubTimestamp":1746712346,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时52分，Co-Diagnostics, Inc.股票出现异动，股价大幅上涨5.69%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体涨幅为0.32%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。该公司还利用其专有技术为其 Co-Dx PCR 平台设计特定测试，并定位用于传染病以外应用的遗传标记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508215226a476d444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508215226a476d444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2533087135","title":"Nanoviricides, Inc.盘中异动 早盘大幅拉升7.18%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533087135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533087135?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:36","pubTimestamp":1746711389,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时36分，Nanoviricides, Inc.股票出现波动，股价急速拉升7.18%。Nanoviricides, Inc.股票所在的生物技术行业中，整体跌幅为2.95%。Nanoviricides, Inc.公司简介：Nanoviricides Inc是一家纳米生物制药公司，致力于发现、开发和商业化治疗剂，以推进对患有危及生命的病毒感染患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213630a6d7c4f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213630a6d7c4f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0},{"id":"2533357341","title":"阿斯利康盘中异动 快速下挫3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533357341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533357341?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:35","pubTimestamp":1746711330,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时35分，阿斯利康股票出现波动，股价大幅下挫3.05%。截至发稿，该股报67.94美元/股，成交量48.6361万股，换手率0.02%，振幅0.69%。阿斯利康股票所在的制药行业中，整体跌幅为1.50%。消息层面，截至21时35分，《安序源科技赴港IPO：连续两年亏损，阿斯利康中金、云锋基金等参投》资讯为影响阿斯利康的重要信息。根据招股书，安序源科技于2023年、2024年分别亏损2285.6万美元和2346.6万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213530aa2c8729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213530aa2c8729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0889565916.HKD","AZN","LU2417539215.USD","BK4568","LU0320765992.SGD","BK4585","LU2462157665.USD","LU2456880835.USD","BK4588","BK4007","LU1829250122.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2533135706","title":"吉利德科学盘中异动 急速下挫3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533135706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533135706?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:33","pubTimestamp":1746711236,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时33分，吉利德科学股票出现波动，股价急速跳水3.02%。截至发稿，该股报95.91美元/股，成交量37.0642万股，换手率0.03%，振幅1.32%。吉利德科学股票所在的制药行业中，整体跌幅为1.15%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821335697534994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821335697534994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","BK4583","IE00BSNM7G36.USD","LU0289739699.SGD","BK4550","BK4139","IE00B19Z3B42.SGD","BK4585","BK4566","LU1066051498.USD","LU1778281490.HKD","BK4578","IE00BKVL7J92.USD","LU0234570918.USD","LU1674673691.USD","BK4532","LU1674673428.USD","LU0889565916.HKD","LU2087621335.USD","LU1430594728.SGD","LU0109394709.USD","LU1585245621.USD","LU1066053197.SGD","BK4568","IE00B19Z3581.USD","IE0002270589.USD","BK4588"],"gpt_icon":0},{"id":"2533394171","title":"Vir Biotechnology, Inc.盘中异动 早盘大幅下跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533394171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533394171?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:32","pubTimestamp":1746711177,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时32分，Vir Biotechnology, Inc.股票出现波动，股价快速下跌5.43%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821325797534979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821325797534979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","VIR","BK4568","BK4585"],"gpt_icon":0},{"id":"2533135051","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨21.18%报7.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533135051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533135051?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:31","pubTimestamp":1746711072,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时31分，诺瓦瓦克斯医药股票出现波动，股价大幅上涨21.18%。截至发稿，该股报7.21美元/股，成交量929.452万股，换手率5.74%，振幅1.51%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为1.65%。其相关个股中，诺瓦瓦克斯医药、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Monte Rosa Therapeutics, Inc.涨幅较大，Nucana Plc、Gri Bio, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为260.94%、41.83%、13.97%，振幅较大的相关个股有Adma Biologics Inc、Aura Biosciences, Inc.、Shattuck Labs, Inc.，振幅分别为10.74%、10.06%、8.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213112a476cef5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213112a476cef5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4139","BK4547","BK4588","BK4568","BK4585"],"gpt_icon":0},{"id":"2533859187","title":"BUZZ-疫苗生产商第一季度扭亏为盈，Novavax 跳涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2533859187","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533859187?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 20:34","pubTimestamp":1746707696,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL4S3RG1LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4585","BK4588","BK4547","NVAX"],"gpt_icon":0},{"id":"2534633341","title":"阿斯利康退出CNS，释放的两个信号","url":"https://stock-news.laohu8.com/highlight/detail?id=2534633341","media":"医药时间","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534633341?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 20:23","pubTimestamp":1746707029,"startTime":"0","endTime":"0","summary":"2016年底，礼来与阿斯利康达成合作协议，共同开发MEDI1814，为此礼来支付了3000万美元的预付款。团队解散与裁员紧随其后，在一季度财报电话会议上，阿斯利康宣布全面退出神经科学领域。阿尔兹海默症也有所突破，FDA批准donanemab用于治疗早期阿尔茨海默病的成年患者。对于阿斯利康来说，专利悬崖近在咫尺，必须做出改变。阿斯利康强调，这一战略调整将“确保资源投向能够带来长期价值的项目”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509030710a6d80d91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509030710a6d80d91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0889565916.HKD","AZN","LU2417539215.USD","BK4568","LU0320765992.SGD","BK4585","LU2462157665.USD","LU2456880835.USD","BK4588","BK4007","CNS","LU1829250122.USD","LU0109394709.USD","BK4135"],"gpt_icon":0},{"id":"2533184058","title":"万艾可制造商 Viatris 因中国市场对品牌药的需求而超出季度预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2533184058","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533184058?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 20:17","pubTimestamp":1746706641,"startTime":"0","endTime":"0","summary":"路透5月8日 - 制药商 Viatris VTRS.O周四公布的第一季度利润和收入超出华尔街预期，主要得益于其品牌药物在中国的销售。在Viatris报告了29亿美元的商誉减值费用后，该公司股价在盘前交易中上涨了1.4%，此前该公司的止痛药和节育贴片在后期研究中获得成功 。Viatris 将这笔费用归因于 \"股价持续大幅下跌，地缘政治和经济环境的不确定性和波动性大幅增加\"。由于减值费用，Viatris 在截至 3 月 31 日的季度中，从去年同期的每股盈利 9 美分转为每股亏损 2.55 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL4T3RG1K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011175.SGD","LU0306807586.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","VTRS","LU1883839398.USD","LU1066051498.USD","LU1839511570.USD","LU0321505868.SGD","IE00BBT3K403.USD","BK4583","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","LU2087621335.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2533318487","title":"Novavax 称正在与 FDA 就 COVID 疫苗审批进行谈判，以平息投资者的担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2533318487","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533318487?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 20:05","pubTimestamp":1746705932,"startTime":"0","endTime":"0","summary":"更新版 3-Novavax 称正在与 FDA 就 COVID 疫苗审批进行谈判，以平息投资者的担忧诺瓦克斯公司承诺在上市后获得 FDA 批准第一季度扭亏为盈股价上涨近 19第 1 段更新股价，第 3 和第 6 段更新电话会议评论Sriparna  Roy. 路透5月8日 - Novavax NVAX.O周四试图安抚因美国监管机构推迟全面批准其COVID疫苗而受到惊吓的投资者，该公司表示，它看到了解决与FDA之间问题的途径，股价在早盘交易中上涨了近19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL4T3RG1J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","LU0985481810.HKD","LU0234572021.USD","BK4581","SG9999001176.SGD","LU1023059063.AUD","LU0058720904.USD","LU0225771236.USD","SG9999002224.SGD","LU1883839398.USD","SG9999002232.USD","SG9999011175.SGD","BK4548","BK4547","LU0289739699.SGD","BK4534","LU0306807586.USD","BK4550","LU1894683348.USD","LU0306806265.USD","BK4139","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999013999.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","IE00BLSP4452.SGD","BK4533","LU1057294990.SGD","IE000M9KFDE8.USD","SG9999001176.USD","BK4532","BK4599","LU0321505868.SGD","LU0868494617.USD","LU1066053197.SGD","BK4568","BK4592","IE00B19Z3581.USD","BK4551","IE0002270589.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU0225284248.USD","BK4007","BK4588"],"gpt_icon":1},{"id":"2533205904","title":"总投资4.75亿美元 阿斯利康无锡小分子药物新工厂正式开工","url":"https://stock-news.laohu8.com/highlight/detail?id=2533205904","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533205904?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 18:16","pubTimestamp":1746699401,"startTime":"0","endTime":"0","summary":"【总投资4.75亿美元 阿斯利康无锡小分子药物新工厂正式开工】5月8日，阿斯利康无锡小分子药物新工厂正式开工。新工厂总投资达4.75亿美元，占地约3万平方米，将装备两套前沿的片剂连续制造工艺设备和七条可持续药品包装生产线，主要生产阿斯利康在研管线中的心血管创新药，预计于2028年第四季度投产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505083399599067.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505083399599067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0109394709.USD","LU2417539215.USD","BK4568","LU2456880835.USD","LU1829250122.USD","BK4585","AZN","BK4007","LU2236285917.USD","LU0320765992.SGD","LU2462157665.USD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2533909490","title":"总投资4.75亿美元 阿斯利康无锡小分子药物新工厂正式开工","url":"https://stock-news.laohu8.com/highlight/detail?id=2533909490","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533909490?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 18:13","pubTimestamp":1746699211,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4588","BK4007","BK4568","159992","AZN","BK1574","BK4585","LU0109394709.USD","LU0889565916.HKD","LU1829250122.USD","LU0320765992.SGD","LU2236285917.USD","LU2417539215.USD","06978","LU2456880835.USD","BK1161","LU2462157665.USD"],"gpt_icon":0},{"id":"2533940180","title":"维尔生物技术公司公布截至 3 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2533940180","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533940180?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 13:47","pubTimestamp":1746683275,"startTime":"0","endTime":"0","summary":"维尔生物技术公司公布截至 3 月 31 日的季度业绩 - 收益摘要Vir Biotechnology Inc VIR.OQ报告，截至3月31日的季度调整后每股亏损88美分，低于去年同期的每股收益-48美分。华尔街预期为每股亏损 1.03 美元至-67 美分。Vir 生物技术公司公布的本季度每股收益为亏损 88 美分。该公司当季亏损 1.2097 亿美元。本季度，Vir Biotechnology Inc 的股价下跌了 13.4%，今年迄今为止下跌了 23.6%。生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Vir 生物技术公司 12 个月目标价的中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL4T3RG0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4535","VIR","BK4139","BK4585"],"gpt_icon":0},{"id":"2533100926","title":"吉利德：再投资110亿美元增建美国工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2533100926","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533100926?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 11:37","pubTimestamp":1746675469,"startTime":"0","endTime":"0","summary":"5月8日，吉利德科学公司Gilead Sciences, Inc.宣布，将投资110亿美元在美国增建更多制药及研究中心。公司表示，相关投资将是在原先已公布的210亿美元投资之上额外增加，主要用以兴建三幢新厂房及提升现有三间工厂，以及引入更先进科技。吉利德估计，110亿美元的新投资可望在2028年前，创设至少800个新职位及2200个间接职位，为美国带来430亿美元经济效益。过去十年该公司已在美国投资150亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508142245a476448f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508142245a476448f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IE0002270589.USD","LU0889565916.HKD","BK4568","LU1571399168.USD","LU1839511570.USD","LU2087621335.USD","IE00BSNM7G36.USD","BK4588","IE00B19Z3581.USD","IE00BKVL7J92.USD","BK4139","BK4583","LU0058720904.USD","LU1066053197.SGD","BK4578","LU1674673691.USD","LU0320765992.SGD","LU1674673428.USD","LU0234570918.USD","LU2468319806.SGD","BK4532","GILD","LU1778281490.HKD","BK4550","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0109394709.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2089984988.USD","LU0289739699.SGD","BK4566","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2533949854","title":"莫德纳5月7日成交额为2.61亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533949854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533949854?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 10:07","pubTimestamp":1746670040,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日，莫德纳成交额为2.61亿美元，成交额较昨日减少55.55%，当日成交量为1081.06万股。莫德纳于2025年5月7日跌1.51%，报24.06美元，该股过去5个交易日跌15.7%，年初至今跌42.14%，过去60日跌24.51%。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508100728a4760db4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508100728a4760db4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","BK4534","BK4139","BK4551","BK4588","BK4548","MRNA","BK4568","BK4532","BK4585","BK4501"],"gpt_icon":1},{"id":"2533437912","title":"吉利德科学再投资110亿美元扩充美国药厂设施","url":"https://stock-news.laohu8.com/highlight/detail?id=2533437912","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533437912?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 09:59","pubTimestamp":1746669592,"startTime":"0","endTime":"0","summary":"美国生化药厂吉利德科学公布，将投资110亿美元在美国增建更多制药及研究中心。公司表示，相关投资将是在原先已公布的210亿美元投资之上额外增加，主要用以兴建三幢新厂房及提升现有三间工厂，以及引入更先进科技。上述计划预期在2030年前完成。吉利德估计，110亿美元的新投资可望在2028年前，创设至少800个新职位及2200个间接职位，为美国带来430亿美元经济效益。总统特朗普提出可能向进口药品开征关税后，包括礼来、强生、默克等多间大药厂，先后公布在美国作出新投资的消息。\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/05/08095950214323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1674673428.USD","LU2089984988.USD","LU1585245621.USD","BK4578","LU1066051498.USD","IE00B3T34201.USD","BK4139","BK4588","LU0320765992.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","IE0002270589.USD","LU2087621335.USD","LU1430594728.SGD","LU1778281490.HKD","BK4568","IE00B19Z3B42.SGD","LU0234570918.USD","GILD","LU2468319806.SGD","IE00B19Z3581.USD","BK4585","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4550","LU0109394709.USD","LU1674673691.USD","IE00BKVL7J92.USD","BK4532","LU1571399168.USD","LU0889565916.HKD","BK4566","BK4583","LU0289739699.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2533919712","title":"吉利德科学5月7日成交额为8.03亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533919712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533919712?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 09:38","pubTimestamp":1746668290,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日，吉利德科学成交额为8.03亿美元，成交额较昨日减少28.59%，当日成交量为812.68万股。吉利德科学于2025年5月7日涨1.04%，报98.9美元，该股过去5个交易日跌7.17%，年初至今涨7.82%，过去60日涨4.31%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508093815a476053a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508093815a476053a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1066053197.SGD","LU1066051498.USD","LU2468319806.SGD","IE00BSNM7G36.USD","BK4139","GILD","BK4550","IE00B19Z3B42.SGD","LU1585245621.USD","LU1430594728.SGD","LU1674673691.USD","IE00B7SZLL34.SGD","BK4585","LU0320765992.SGD","LU0109394709.USD","LU0289739699.SGD","LU1839511570.USD","BK4532","BK4583","BK4588","LU1571399168.USD","LU0234570918.USD","BK4566","LU1674673428.USD","LU2087621335.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4578","LU0058720904.USD","LU1778281490.HKD","IE0002270589.USD","LU0889565916.HKD","IE00B3T34201.USD","BK4568"],"gpt_icon":0},{"id":"2533679913","title":"雅培5月7日成交额为6.58亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533679913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533679913?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 09:15","pubTimestamp":1746666917,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日，雅培成交额为6.58亿美元，成交额较昨日减少21.12%，当日成交量为492.52万股。雅培于2025年5月7日涨0.67%，报133.95美元，该股过去5个交易日涨2.45%，年初至今涨19.59%，过去60日涨2.48%。雅培约 60% 的销售额来自美国以外地区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508091535a475ff4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508091535a475ff4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1691799644.USD","BK4533","LU2089984988.USD","BK4592","BK4581","LU1057294990.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2237957811.SGD","IE0009355771.USD","SG9999004303.SGD","IE00B2B36J28.USD","LU0234572021.USD","LU1061106388.HKD","SG9999002232.USD","BK4568","LU1914381329.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU1721429741.USD","LU0868494617.USD","LU1721429402.USD","SG9999002224.SGD","BK4588","BK4566","BK4082","BK4504","LU0170899867.USD","LU0266013472.USD","LU0122379950.USD","SGXZ23171101.USD","ABT","IE0002141913.USD","LU2237957902.USD","BK4585","LU1989763690.USD","LU1989763427.SGD"],"gpt_icon":0},{"id":"2533295011","title":"吉利德公司宣布在美国新投资 110 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533295011","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533295011?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 02:48","pubTimestamp":1746643713,"startTime":"0","endTime":"0","summary":"吉利德公司宣布在美国新投资 110 亿美元路透5月7日 - 吉利德科学公司GILD.O周三宣布将在美国进行110亿美元的资本和运营投资，以补充已计划到2030年在国内生产和研发领域投入的210亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL4S3RF23E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","IE00BSNM7G36.USD","LU1674673691.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU2087621335.USD","BK4566","BK4568","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU0320765992.SGD","LU1778281490.HKD","BK4578","IE00B19Z3581.USD","GILD","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD","LU1674673428.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":187,"code":"91000000","status":"200"}]}}